{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/49596700"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "cose concentration in diabetic patients and improving glucose tolerance, comprises insulin and glucagon-like peptide-1 agonistDE102009038210A1Aug 20, 2009Mar 3, 2011Sanofi-Aventis Deutschland GmbhMedicament, useful e.g. for treating diabetes, controlling fasting, postprandial or postabsorptive blood glucose concentration in diabetic patients and improving glucose tolerance, comprises insulin and g" ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "google.com" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/344146906"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/49596700"] } } }
